WMSA
CRDF icon

Weiss Multi-Strategy Advisers’s Cardiff Oncology CRDF Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-681
Closed -$220K – 429
2016
Q3 		$220K Sell
681
-230
-25% -$83.8K 0.01% 393
2016
Q2 		$297K Sell
911
-617
-40% -$213K 0.02% 354
2016
Q1 		$512K Hold
1,528
– – 0.02% 384
2015
Q4 		$594K Hold
1,528
– – 0.04% 292
2015
Q3 		$626K Buy
1,528
+1,181
+340% +$618K 0.03% 303
2015
Q2 		$254K Sell
347
-313
-47% -$222K 0.01% 409
2015
Q1 		$323K Buy
+660
New +$282K 0.01% 394

Other funds holding CRDF

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CRDF Position: Q4 2016 in Review

Weiss Multi-Strategy Advisers sold out of Cardiff Oncology (CRDF) in Q4 2016, closing a stake of 681 shares — an estimated $220K sold.

Weiss Multi-Strategy Advisers first reported a position in CRDF in Q1 2015 and held it in 7 quarters. The position peaked at $626K in Q3 2015. 68 funds tracked by Wall St. Rank hold CRDF as of Q4 2016.

  • Weiss Multi-Strategy Advisers reported no remaining Cardiff Oncology position as of Q4 2016 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 681 Cardiff Oncology shares in Q4 2016, an estimated $220K.
  • Weiss Multi-Strategy Advisers first reported a position in Cardiff Oncology in Q1 2015 and held it in 7 quarters.
  • Weiss Multi-Strategy Advisers's Cardiff Oncology position peaked at $626K in Q3 2015.
  • 68 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2016.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.